TW202039582A
|
|
Anti-epcam antibody and use thereof
|
TW202102204A
|
|
Pharmaceutical composition comprising anti-il-5 antibody and uses thereof
|
TW202102505A
|
|
A pyrroloheterocyclic derivative and preparation method and medical use thereof
|
TW202100150A
|
|
Application of multi-target tyrosine kinase inhibitor combined with egfr inhibitor in preparing medicine for treating tumor
|
TW202102480A
|
|
6-oxo-1,6-dihydropyridazine prodrug derivative, preparation method therefor, and medical applications thereof
|
TW202045493A
|
|
2-aminopyrimidine derivatives, a preparation method thereof and a medical use thereof
|
TW202045538A
|
|
Anti-pd-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof
|
TW202043233A
|
|
Crystal forms of 1,2,3-triazolo [1,5-a] pyrazine derivatives and manufacturing method thereof
|
TW202043200A
|
|
2-oxo-1,2-dihydropyridin derivative, a preparation method thereof and a medical use thereof
|
TW202043197A
|
|
Crystal form of indole formamide derivative and preparation method thereof
|
TW202024134A
|
|
A bispecific protein
|
TW202034945A
|
|
Human interleukin 2 variant or derivatives thereof
|
TW202034925A
|
|
Use of cdk4/6 inhibitor in combination with immunotherapy for preparation of medicament for treating lymphoma
|
TW202021987A
|
|
Cd3 antibody and its pharmaceutical use thereof
|
TW202039558A
|
|
Anti-cd40 antibody, antigen-binding fragments and pharmaceutical use thereof
|
TW202039001A
|
|
Use of anti-pd-1 antibody in combination with famitinib for preparation of medicament for treating tumor diseases
|
TW202014423A
|
|
Indole macrocyclic derivatives, a preparation method thereof and medical use thereof
|
TW202027787A
|
|
Use of ezh2 inhibitor in combination with immune checkpoint inhibitor for preparation of medicament for treating tumor diseases
|
AU2019351427A1
|
|
Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof
|
AU2019347934A1
|
|
An anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use
|